Infusion Therapy Market Growth, Revenue Share Analysis, Company Profiles, and Forecast To 2032

The global infusion therapy market has shown significant growth in recent years and is projected to continue expanding in the coming years. In 2022, the market size was valued at USD 44.2 billion, and it is expected to reach USD 74.67 billion by 2032, growing at a compound annual growth rate (CAGR) of 6% during the forecast period.

One of the key drivers of this growth is the increasing prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal problems. The management of these conditions often requires infusion therapy, making it an essential component of the healthcare system. As the aging population continues to increase, the occurrence of chronic conditions that necessitate infusion therapy is becoming more common among the elderly.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/2601

Some major companies included in the global infusion therapy market report are:

• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company
• Fresenius Kabi AG
• Hospira, Inc.
• ICU Medical, Inc.
• Smiths Medical
• Terumo Corporation

Furthermore, advancements in medication delivery techniques and technology have contributed to the market’s revenue growth. Infusion pumps, in particular, have undergone significant improvements in recent years. The development of smart pumps has enabled real-time monitoring of patient vital signs and has the potential to reduce prescription errors.

Overall, the infusion therapy market is poised for substantial growth due to the rising prevalence of chronic diseases, technological advancements in infusion pumps, and the increasing aging population. These factors are expected to drive the demand for infusion therapy and contribute to the market’s expansion in the coming years.

By Product Type Outlook            

• Intravenous Sets (IV)
• Infusion Pumps
• Needleless Connectors
• Others

By Application Outlook

• Chemotherapy
• Diabetes
• Clinical Nutrition
• Pain Management
• Others

Regional Outlook:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

PARAMETERS	DETAILS
The market size value in 2022	USD 44.2 Billion
CAGR (2022 – 2032)	6%
The Revenue forecast in 2032	USD 74.67 Billion
Base year for estimation	2022
Historical data	2020-2021
Forecast period	2022-2032
Quantitative units	Revenue in USD Billion CAGR from 2022 to 2032
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	By Product Type Outlook, Application Outlook, Regional Outlook
By Product Type Outlook	Intravenous Sets (IV) Infusion Pumps Needleless Connectors Others
By Application Outlook	Chemotherapy Diabetes Clinical Nutrition Pain Management Others
Regional scope	North America; Europe; Asia Pacific; Latin America ; Middle East & Africa
Country scope	U.S.; Canada; U.K.; Germany; France; BENELUX; China; India; Japan; South Korea; Brazil; Saudi Arabia; UAE; Turkey
Key companies profiled	B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Fresenius Kabi AG, Hospira Inc, ICU Medical Inc, Smiths Medical, Terumo Corporation
Customization scope	10 hrs of free customization and expert consultation

Key Advantages of Infusion Therapy Report:

• Identification and analysis of the market size and competition
• Qualitative and quantitative analysis of the market data
• Data validated by industry experts after extensive primary and secondary research
• Extensive regional analysis of the Infusion Therapy industry
• Profiling of key players along with their business overview,  business strategies, deals and partnerships, and product portfolio
• SWOT and Porter’s Five Forces Analysis for in-depth understanding of the competitive landscape
• Feasibility analysis and investment analysis to enable strategic investment decisions
• Analysis of opportunities, drivers, restraints, challenges, risks, and limitations

Strategic Developments:

• In 2021, Becton, Dickinson and Company announced the acquisition of GSL Solutions, Inc., a privately held medical device software company. The acquisition was aimed at strengthening BD’s Pyxis medication management platform by integrating GSL’s technology into it.

Table of Content

• 1.

  Market Synopsis

  • 1.1.

    Market Definition

  • 1.2.

    Research Scope And Premise

  • 1.3.

    Research Methodology

  • 1.4.

    Market Estimation

• 2.

  Executive Summary

  • 2.1.

    Summary Snapshot, 2022 – 2032

• 3.

  Indicative Metrics

• 4.

  Infusion Therapy Market Segmentation & Impact Analysis

  • 4.1.

    Infusion Therapy Market Segmentation Analysis

  • 4.2.

    Industrial Outlook

    • 4.2.1.

      Market Indicators Analysis

    • 4.2.2.

      Market Drivers Analysis

    • 4.2.3.

      Market Restraints Analysis

  • 4.3.

    Technological Insights

  • 4.4.

    Regulatory Framework

  • 4.5.

    Etop Analysis

  • 4.6.

    Porter’s Five Forces Analysis

  • 4.7.

    Price Trend Analysis

  • 4.8.

    Customer Mapping

  • 4.9.

    Covid-19 Impact Analysis

  • 4.10.

    Global Recession Influence

• 5 Infusion Therapy Market By Product Type Outlook

  •  5.1 Product Type Outlook Dynamics & Market Share, 2022 & 2032

  •  5.2 Intravenous Sets (Iv)

    •  5.2.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  5.2.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  5.3 Infusion Pumps

    •  5.3.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  5.3.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  5.4 Needleless Connectors

    •  5.4.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  5.4.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  5.5 Others

    •  5.5.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  5.5.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

• 6 Infusion Therapy Market By Application Outlook

  •  6.1 Application Outlook Dynamics & Market Share, 2022 & 2032

  •  6.2 Chemotherapy

    •  6.2.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  6.2.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  6.3 Diabetes

    •  6.3.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  6.3.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  6.4 Clinical Nutrition

    •  6.4.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  6.4.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  6.5 Pain Management

    •  6.5.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  6.5.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

  •  6.6 Others

    •  6.6.1 Market Estimates And Forecast, 2022-2032 (USD BILLION)

    •  6.6.2 Market Estimates And Forecast, By Region, 2022-2032 (USD BILLION)

Conclusively, all aspects of the Infusion Therapy market are quantitatively as well qualitatively assessed to study the global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and its future prospects